Revenue continues to grow strongly

PO Box 1387, Gisborne 4040, Aotearoa New Zealand | 0800 RUABIO | www.ruabio.com



FOR PUBLIC RELEASE

NZX Limited
Wellington

18 November 2024

Revenue continues to grow

Rua Bioscience Limited (“RUA”) is pleased to report continued month-on-month growth in
sales revenue, as seen in our latest figures below (unaudited). With our products now
available in three key markets - Aotearoa NZ, Australia and Germany - Rua is establishing a
strong national and international presence.


Revenue – NZ$000
Jul 24 – Oct 24 are unaudited figures

Looking ahead, we are launching products in the UK within the next month, a move that we
anticipate will further accelerate our strong growth trajectory. And we will also have new
products in Aotearoa and Germany before the end of this year.

Our current revenue trajectory along with new product offerings in key markets give us
confidence in our business plan. We are forecasting revenue over $3mill by the end of FY25.

ENDS  
 
The person who authorised this announcement:

Paul Naske
Chief Executive Officer
paul.naske@ruabio.com
+64 21 445154
6 k
16 k
23 k
24 k
82 k
122 k
128 k
Apr-24 May-24 Jun-24 Jul-24 Aug-24 Sep-24 Oct-24
MARKET UPDATE